救心复脉注射液治疗心源性休克的临床研究  

Clinical Study of Jiuxin Fumai Injection in Treatment of Cardiogenic Shock

作　　者：黄道生[1] 杨剑刚[1] 李灿[1] 刘剑平 

机构地区：[1]湖南医科大学附属第二医院,长沙410011

出　　处：《中国中西医结合杂志》1998年第10期590-593,共4页Chinese Journal of Integrated Traditional and Western Medicine

基　　金："八五"国家重点科技 (攻关 )资助课题之一

摘　　要：目的 :验证救心复脉注射液 (CA)治疗心源性休克的临床疗效。方法 :用CA静脉给药治疗心源性休克 2 0例 (其中AMI 1 5例 ) ,用多巴胺注射液 (DA)作对照 (1 1例 )。结果 :CA组有效 1 8例 (90 0 % ) ,无效 2例 (1 0 0 % ) ;DA组有效 9例 (81 8% ) ,无效 2例 (1 8 2 % ) ,组间比较 ,P >0 0 5。结论 :CA和DA均能升高血压 ,增加心泵功能 ,改善厥脱证的症脉 ,但CA比DA升压速度快 ,幅度高 ,作用稳定 ,对心率有双相调节作用 ,使心动过速患者心率减慢 ,使心动过缓患者心率增快。Objective: To increase the cure and improvement rates and to decrease the mortality rate in the treatment of cardiogenic shock. Methods: Thirty one patients with cardiogenic shock were studied, and received Jiuxin Fumai injection (JXFM) in research group (n=20) or dopamine (DA) in control group (n=11). Results: Eighteen effective cases (90.0%) and 2 ineffective cases (10.0%) in JXFM group, 9 effective cases (81.8%) and 2 ineffective cases (18.2%) in DA group. There was insignificant difference statistically, P>0 05. Conclusions: JXFM and DA had the same effect in elevating blood pressure, enhancing pump function of the heart and ameliorating collapse syndrome. They are safe, effective, convenient for use and prompt in responding. However, JXFM showed raising blood pressure faster, higher as well as more stable, and the dual phase phenomenon in adjusting heart rate, which could slow down tachycardia as well as speed up bradycardia were observed.

关 键 词：救心复脉注射液 心力衰竭 心源性休克 厥脱证 

分 类 号：R259.416.4[医药卫生—中西医结合]